Eliav Barr
Vermogen: 2 M $ op 31-08-2026
Vermogen: 2 M $ op 31-08-2026
Eliav Barr is currently an Independent Director at Veracyte, Inc. since 2022.
Dr. Barr is also the Chief Medical Officer at Merck Research Laboratories Massachusetts LLC since 2022.
Dr. Barr completed undergraduate studies at The Pennsylvania State University and earned a doctorate from Sidney Kimmel Medical College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERACYTE, INC. 0,07% | 11-06-2026 | 56.461 ( 0,07% ) | 2 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VERACYTE, INC. | Directeur/Bestuurslid | 09-08-2022 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Sidney Kimmel Medical College
Sidney Kimmel Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau